Quick Summary

Cassia Bark (Cinnamomum cassia) is a traditional herbal ingredient extensively used in food, pharmaceuticals, and traditional medicine systems. Its chemical composition includes volatile oils such as trans-cinnamaldehyde along with a broad range of non-volatile metabolites. Clinical evidence suggests potential benefits in glycemic control and improvement of cardiovascular risk factors, primarily within the context of type 2 diabetes mellitus. Cassia Bark is commonly included in multi-herbal formulations in traditional Chinese medicine (TCM) to manage metabolic, cardiovascular, and inflammatory conditions. However, clinical trial data specifically investigating Cassia Bark alone remain limited, with most conclusions derived from studies involving multi-herb formulas containing it as a key component.

What Is It?

Cassia Bark refers to the dried inner bark of Cinnamomum cassia, a tree native to China and widely cultivated in other parts of Asia. It is closely related to true cinnamon (Cinnamomum verum), but differs in flavor profile and chemical constituents. Cassia Bark is used as a spice, flavoring agent, and herbal medicine.

Traditional Uses

Traditionally, Cassia Bark has been utilized in Chinese herbal medicine for its warming properties. It has been employed to support digestive health, promote circulation, and alleviate symptoms related to metabolic and cardiovascular disorders. It is commonly combined with other herbs in formulas aimed at managing diabetes, inflammatory conditions, and various systemic imbalances.

Active Compounds

The main active compounds identified in Cassia Bark include:

  • Trans-cinnamaldehyde: A volatile oil contributing to aroma and potential biological activity.
  • Other volatile oils: Such as eugenol and cinnamic acid derivatives.
  • Non-volatile metabolites: Including polyphenols, tannins, and coumarins which may contribute to antioxidant and anti-inflammatory effects.

Potential Benefits with Evidence Levels

Type 2 Diabetes Mellitus

  • Reduction in fasting blood glucose.
  • Improvement in HbA1c (glycated hemoglobin).
  • Enhanced insulin sensitivity.
  • Reduction in inflammatory markers and lipid profile parameters (total cholesterol, LDL, triglycerides).

Evidence level: Moderate quality evidence from multiple randomized controlled trials and meta-analyses involving cinnamon-containing preparations; some studies specifically include Cinnamomum cassia. Benefits are more noticeable when used adjunctively with conventional treatments.

Cardiovascular Risk Factors

  • Reduction in systolic and diastolic blood pressure.
  • Reduction in waist circumference.
  • Improvement in lipid profiles (increased HDL cholesterol, reduced LDL cholesterol, total cholesterol, and triglycerides).

Evidence level: Moderate-quality evidence from systematic reviews and meta-analyses of cinnamon supplementation including Cinnamomum cassia. Supported by randomized controlled trial data.

Diabetic Foot (Wagner Grade 0 or 1)

  • Improved clinical effective rate.
  • Improvement in vascular and nerve function parameters.
  • Reduction in HbA1c and fasting blood glucose levels.

Evidence level: Limited moderate evidence from a meta-analysis of Chinese herbal footbaths containing Cinnamomum cassia combined with other herbs. Safety profile appears acceptable with no significant rise in adverse events.

Side Effects

Cassia Bark has generally been reported as safe in clinical studies involving cinnamon-containing formulations. No serious adverse events specifically attributed to Cassia Bark alone have been documented. Some trials report mild gastrointestinal discomfort associated with cinnamon extracts, but these findings are inconsistent. Mild skin irritation has been reported with topical herbal formulas containing multiple ingredients, though not specifically linked to Cassia Bark. Adverse effects are infrequently reported and usually mild when present.

Drug Interactions

There is no direct evidence from human clinical studies on drug interactions specific to Cassia Bark. However, because cinnamon compounds may influence blood glucose levels and platelet function, caution is advised when used concurrently with hypoglycemic agents or anticoagulants. A comprehensive evaluation of potential herb-drug interactions is recommended due to limited direct evidence.

Who Should Avoid It

  • Individuals with known hypersensitivity or allergy to cinnamon or related compounds should exercise caution.
  • Pregnant and breastfeeding women – due to lack of safety data, use is generally not recommended or should be avoided during pregnancy and lactation.
  • People taking medications for blood sugar control or blood thinning should consult healthcare professionals prior to use.

Evidence Limitations

  • Most clinical studies involve multi-herb formulations including Cassia Bark, limiting conclusions about its isolated effects.
  • Heterogeneity in study designs, doses, treatment durations, and patient populations reduces certainty about specific efficacies.
  • Safety data specific to Cassia Bark monotherapy are sparse and mostly extrapolated from studies involving general cinnamon supplementation or combination therapies.
  • Limited high-quality, large-scale randomized controlled trials focusing exclusively on Cassia Bark.
  • Potential variability in phytochemical composition due to botanical source, preparation methods, and dosage is insufficiently characterized.
  • Lack of controlled studies addressing herb-drug interactions and contraindications specific to Cassia Bark.
  • Insufficient data on safety for special populations such as pregnant or breastfeeding women.

References

Last Reviewed

April 2024

Disclaimer: This page is for informational purposes only and does not constitute medical advice. The efficacy and safety of Cassia Bark have not been established for all uses. Always consult a healthcare professional before starting any new supplement or herbal therapy, especially if you have existing health conditions or are taking medications.